全文获取类型
收费全文 | 32691篇 |
免费 | 2238篇 |
国内免费 | 110篇 |
专业分类
耳鼻咽喉 | 258篇 |
儿科学 | 1321篇 |
妇产科学 | 974篇 |
基础医学 | 4432篇 |
口腔科学 | 404篇 |
临床医学 | 4203篇 |
内科学 | 6273篇 |
皮肤病学 | 630篇 |
神经病学 | 3486篇 |
特种医学 | 728篇 |
外国民族医学 | 5篇 |
外科学 | 3154篇 |
综合类 | 341篇 |
一般理论 | 32篇 |
预防医学 | 3845篇 |
眼科学 | 558篇 |
药学 | 1908篇 |
中国医学 | 56篇 |
肿瘤学 | 2431篇 |
出版年
2024年 | 39篇 |
2023年 | 253篇 |
2022年 | 463篇 |
2021年 | 921篇 |
2020年 | 577篇 |
2019年 | 953篇 |
2018年 | 1024篇 |
2017年 | 716篇 |
2016年 | 827篇 |
2015年 | 860篇 |
2014年 | 1216篇 |
2013年 | 1790篇 |
2012年 | 2652篇 |
2011年 | 2707篇 |
2010年 | 1505篇 |
2009年 | 1242篇 |
2008年 | 2170篇 |
2007年 | 2340篇 |
2006年 | 2268篇 |
2005年 | 2141篇 |
2004年 | 1906篇 |
2003年 | 1762篇 |
2002年 | 1692篇 |
2001年 | 227篇 |
2000年 | 171篇 |
1999年 | 218篇 |
1998年 | 319篇 |
1997年 | 284篇 |
1996年 | 216篇 |
1995年 | 188篇 |
1994年 | 152篇 |
1993年 | 186篇 |
1992年 | 108篇 |
1991年 | 90篇 |
1990年 | 67篇 |
1989年 | 65篇 |
1988年 | 78篇 |
1987年 | 40篇 |
1986年 | 45篇 |
1985年 | 41篇 |
1984年 | 54篇 |
1983年 | 52篇 |
1982年 | 52篇 |
1981年 | 44篇 |
1980年 | 52篇 |
1979年 | 34篇 |
1978年 | 36篇 |
1977年 | 24篇 |
1975年 | 18篇 |
1973年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
John M. Meredith Catherine J. Auger Jeffrey D. Blaustein 《Journal of neuroendocrinology》1994,6(6):639-648
Low amplitude pulses of estradiol-17β (E2-17β) are more effective than large single bolus injections or constant exposure to E2-17β in inducing progesterone-facilitated sex behavior in female rats and guinea pigs. The present study examined whether the increased responsiveness to E2-17β is due to an increase in the number of estrogen receptors in the estrogen receptor rich areas of the hypothalamus and amygdala. Initial studies examined the rapid effects (20 min) of a high dose of E2-17β (50 μg) on estrogen receptor immunostaining using either the H222 antibody or the ER 21 antiserum. ER 21 immunostaining was not affected by the E2-17β treatment suggesting that it binds to both occupied and unoccupied estrogen receptors. Therefore the ER 21 antiserum was used to characterize the regulation of estrogen receptor immunoreactivity (ER-IR) by E2-17β. ER-IR was examined for 48 h and serum E2-17β for 24 h following a 2 μg s.c. injection of E2-17β (a dose similar to that used in multiple pulse paradigms). Serum E2-17β peaked 15 to 30 min following the injection and returned to baseline values by 1 h. In all but one area maximal suppression of ER-IR occurred at 12 h. In summary, 1) decreases in estrogen receptor immunoreactivity following E2-17β are consistent with studies in which estrogen receptors were assayed by binding assays and estrogen receptor mRNA was determined by in situ hybridization; 2) the ER 21 antiserum is able to detect both occupied and unoccupied estrogen receptors and 3) H222 immunoreactivity is influenced by the presence of E2-17β, so that the level of H222-IR is a reflection of ligand/receptor binding dynamics. The data suggest that up-regulation of estrogen receptors does not account for the increase in behavioral sensitivity which is observed following multiple pulses of E2-17β. 相似文献
82.
83.
Methotrexate for the treatment of unruptured tubal pregnancy: a prospective nonrandomized study. 总被引:3,自引:0,他引:3
Amélie Gervaise Sylvie Capella-Allouc Fran?ois Audibert Catherine Rongières-Bertrand Yves Vincent Hervé Fernandez 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2003,7(3):233-238
BACKGROUND AND OBJECTIVES: The aim of this study was to compare in a prospective nonrandomized study, the efficacy of 2 methods of administering methotrexate (MTX) in the treatment of ectopic pregnancy (EP): transvaginal injection under sonographic control or intramuscular injection (IM). METHODS: Patients with EP who met specific inclusion criteria for medical treatment were treated with MTX: 63 patients (group 1) were treated by IM and 47 patients (group 2) by transvaginal local injection. In group 1, 50 mg/m2 of MTX was injected intramuscularly; in group 2, transvaginal injection of 1 mg/kg of MTX was injected into the ectopic sac under sonographic control. When an additional dose of MTX was required, it was administrated IM at the dosage of 50 mg/m2 in both groups. RESULTS: The overall success rate, defined by a posttreatment normal hCG level (< 10 mUI/mL) was 71.4% in group 1 versus 91.5% in group 2 (P < 0.01); for patients with hCG levels < 2000 mUI/mL, 83% and 96%, respectively (not significant); for patients with hCG > or = 2000 mUI/mL, 37.5% and 86.4%, respectively (P < 0.01). CONCLUSION: In the medical treatment of EP, the efficacy of MTX is greater when administered by local transvaginal injection than by IM injection. We propose local treatment every time EP can be punctured, especially when hCG levels are > or = 2000 mUI/mL. 相似文献
84.
85.
86.
Bryce A. Kiberd Tammy Keough-Ryan Catherine M. Clase 《American journal of transplantation》2003,3(5):619-625
American Society of Transplantation guidelines recommend screening renal transplant recipients for breast, colorectal and prostate cancer. However there is a lack of evidence to support this practice. Computer simulation modeling was used to estimate the years of life lost as a result of these cancers in 50-year-old renal transplant recipients and subjects in the general population. Renal transplant recipients lost fewer years of life to cancer than people in the general population largely because of reduced life expectancy. In nondiabetic transplant recipients, loss of life as a result of these cancers was comparable with that in the general population only under assumptions of increased cancer incidence and cancer-specific mortality risks. Even with two-fold higher cancer incidence and disease-specific mortality risks, diabetic transplant recipients lost considerably fewer life years to cancer than those in the general population. Recommended cancer screening for the general population may not yield the expected benefits in the average renal transplant recipient but the benefits will be considerably higher than for patients on dialysis. Transplanted patients at above-average cancer risk in good health may achieve the benefits of screening that are seen in the general population. 相似文献
87.
Gérard Brunel Edmond Benqué Frédéric Elharar Catherine Sansac Jean François Duffort Pierre Barthet Eric Baysse Neal Miller 《Clinical oral implants research》1998,9(5):303-312
The aim of the present study was to evaluate the combined application of different bioabsorbable materials for healing of residual peri‐implant defects after placement of non‐submerged implants into fresh extraction sockets. Second and third mandibular premolars were extracted from 10 Beagle dogs, the coronal part of the distal sockets were surgically enlarged and this was followed by immediate placement of specially designed hollow‐screw non‐submerged dental implants. For each animal, the coronal peri‐implant defects were further treated with one of the 4 following procedures: 1) no treatment, control site: 2) grafting with porous hydroxyapatite (HA); 3) collagen membrane tightly secured around the implant and over the defect and 4) grafting with HA covered with a collagen membrane. After 16 weeks of healing, specimens were removed from the mandibule and prepared for a histomorphometric evaluation. The bone-to-implant contact length (BIC) was measured and compared amongst the different treatment modalities. In the defect area, the irregular bone regeneration was similar between all the treatment procedures ( P >0.10). In the sites covered with a collagen membrane alone, the total BIC (47%) was greater than in control sites (28.7%. P <0.05) or sites grafted with HA (22.2%, P <0.02). Total BIC in sites treated with the HA‐membrane combination (43%) was only significantly different from sites treated with HA ( P <0.10). It is concluded that the use of bioabsorbable materials results in a limited increase of osseointegration when used in conjunction with immediate placement of non-submerged implants, although the principle of the one stage surgical approach can be maintained. 相似文献
88.
Dr. Hershel Jick M.D. Dr. Laura E. Derby D.Sc. Dr. Victor Gurewich M.D. Mr. Catherine Vasilakis M.P.H. 《Pharmacotherapy》1996,16(3):321-326
We conducted a case-control study based on computer-recorded information accrued in the United Kingdom General Practice Research Database to assess and compare the relation between different antihypertensive drug therapies and myocardial infarction in patients with no known clinical or laboratory risk factors for myocardial infarction other than hypertension. Cases were treated hypertensive patients with no other known risk factors who developed a first acute myocardial infarction between January 1, 1993, and October 31, 1994. They were ascertained from a review of the clinical record together with a questionnaire filled out by the attending general practitioner. Controls were matched to each case for age, sex, general practice, and index date. Antihypertensive therapy was derived from the computerized patient record. The study consisted of 210 cases and 793 controls. Compared with users of β-blockers alone, the adjusted relative risk (RR) estimates for all other treatment regimens were close to 1.0. A comparison of users of calcium channel blockers alone with users of β-blockers alone yielded a RR estimate of 0.9 (95% CI 0.5, 1.7). We conclude that the risk of acute myocardial infarction in otherwise healthy, treated hypertensive patients is not materially associated with the particular drug they receive. 相似文献
89.
90.
Julie D Rippeth Robert K Heaton Catherine L Carey Thomas D Marcotte David J Moore Raul Gonzalez Tanya Wolfson Igor Grant 《Journal of the International Neuropsychological Society》2004,10(1):1-14
Both HIV infection and methamphetamine dependence can be associated with brain dysfunction. Little is known, however, about the cognitive effects of concurrent HIV infection and methamphetamine dependence. The present study included 200 participants in 4 groups: HIV infected/methamphetamine dependent (HIV+/METH+), HIV negative/methamphetamine dependent (HIV-/METH+), HIV infected/methamphetamine nondependent (HIV+/METH-), and HIV negative/methamphetamine nondependent (HIV-/METH-). Study groups were comparable for age, education, and ethnicity, although the HIV-/METH- group had significantly more females. A comprehensive, demographically corrected neuropsychological battery was administered yielding a global performance score and scores for seven neurobehavioral domains. Rates of neuropsychological impairment were determined by cutoff scores derived from performances of a separate control group and validated with larger samples of HIV+ and HIV- participants from an independent cohort. Rates of global neuropsychological impairment were higher in the HIV+/METH+ (58%), HIV-/METH+ (40%) and HIV+/METH- (38%) groups compared to the HIV-/METH- (18%) group. Nonparametric analyses revealed a significant monotonic trend for global cognitive status across groups, with least impairment in the control group and highest prevalence of impairment in the group with concurrent HIV infection and methamphetamine dependence. The results indicate that HIV infection and methamphetamine dependence are each associated with neuropsychological deficits, and suggest that these factors in combination are associated with additive deleterious cognitive effects. This additivity may reflect common pathways to neural injury involving both cytotoxic and apoptotic mechanisms. 相似文献